Gender influence on treatment of chronic hepatitis C genotype 1 Influência do gênero no tratamento da hepatite C crônica genótipo 1

Gender influence on treatment of chronic hepatitis C genotype 1 Influência do gênero no tratamento da hepatite C crônica genótipo 1

INTRODUCTION: Although various studies have been published regarding the treatment of chronic hepatitis C (CHC) with peginterferon (Peg-IFN) and ribavirin, little is known regarding the real impact of gender on the characteristics that influence the effectiveness and safety of antiviral treatment fo...

Full description

Bibliographic Details
Main Authors:	Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon, Roberto José Carvalho-Filho, Juliana Peghini Sampaio, Philipe Nicolas El Batah, Denize Vieira Barbosa, Maria Lucia Gomes Ferraz, Antonio Eduardo Benedito Silva
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2010-06-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Hepatite C Interferon peguilado Ribavirina Gênero Mulheres Hepatitis C Pegylated interferon Ribavirin Gender Women
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822010000300001

Similar Items

Hepatite C
by: Edna Strauss
Published: (2001-02-01)

Tratamento de pacientes com hepatite crônica pelo vírus C com interferon-alfa e ribavirina: a experiência da Secretaria de Saúde do Rio Grande do Sul Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil
by: Alexandro Vaesken Alves, et al.
Published: (2003-12-01)

A taxa de resposta sustentada da hepatite C crônica ao tratamento com os diversos interferons-alfa e ribavirinas distribuídos pelo governo brasileiro é semelhante à da literatura mundial The sustained response rates for chronic hepatitis C patients undergoing therapy with the several interferons and ribavarins supplied by Brazilian’s Health Ministry is comparable to those reported in the literature
by: Rafael Nastás Acras, et al.
Published: (2004-03-01)

Interferon convencional versus interferon peguilado associados à ribavirina no tratamento de pacientes coinfectados pelo vírus da hepatite C (genótipo 1) e da imunodeficiência humana Alpha-interferon versus peg-interferon associated to ribavirin in the treatment of genotype 1 hepatitis C virus and human imunodeficiency virus coinfected patients
by: Paulo Roberto Lerias de Almeida, et al.
Published: (2009-06-01)

Tratamiento de hepatitis C en la insuficiencia renal crónica terminal en hemodiálisis con Interferón 2 b y ribavirina: A case report Treatment of hepatitis C in end-stage chronic renal failure in hemodialysis with Interferon 2 b and ribavirine
by: Yanet Parodis López, et al.
Published: (2005-08-01)

Molde brônquico devido ao uso de interferon peguilado e ribavirina Bronchial casts attributed to the use of pegylated interferon and ribavirin
by: Eduardo Garcia, et al.
Published: (2009-07-01)

Should active injecting drug users receive treatment for chronic hepatitis C? Usuários ativos de drogas injetáveis devem receber tratamento para hepatite crônica tipo C?
by: Vasileios Papadopoulos, et al.
Published: (2010-09-01)

Daily interferon induction regimen using different manufactured interferons (alpha-2a or alpha-2b) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study Esquema de indução diário com interferon alfa 2-a ou alfa 2-b em combinação com ribavirina para tratamento da hepatite crônica C: estudo prospectivo randomizado
by: Eduardo Lorens Braga, et al.
Published: (2006-12-01)

Celiac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C Doença celíaca após tratamento de hepatite C crônica com interferon peguilado e ribavirina
by: Elson V. Martins Jr., et al.
Published: (2004-06-01)

New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C
by: Markus Cornberg, et al.
Published: (2005-07-01)

Real-life results of sofosbuvir based therapy for patients with hepatitis C
by: D. G. Zhivitsa, et al.
Published: (2019-09-01)

Secondary bronchiolitis obliterans organizing pneumonia during treatment of chronic hepatitis C: role of pegylated interferon alfa-2a
by: Ronaldo Soares Martins, et al.
Published: (2012-10-01)

Predictive baseline criteria of primary therapeutic failure in chronic hepatitis C genotype 1 Criterios predictivos basales de fracaso terapéutico primario en la hepatitis crónica C genotipo 1
by: F. Cuenca, et al.
Published: (2010-04-01)

Chronic hepatitis C treatment in a cystic fibrosis patient in the pulmonary pre-transplant stage Tratamiento de hepatitis crónica C en un paciente con fibrosis quística en situación de pretrasplante pulmonar
by: L. Adán Merino, et al.
Published: (2010-10-01)

Emerging Therapies for Hepatitis C
Published: (2014-09-01)

Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin Anemia hemolítica auto-imune durante o tratamento da hepatite crônica com interferon peguilado alfa 2a e ribavirina, em pacientes com co-infecção HCV/HIV
by: Fernando Crivelenti Vilar, et al.
Published: (2007-12-01)

Telaprevir: New possibilities for antiviral treatment in patients with chronic hepatitis C
by: I G Nikitin, et al.
Published: (2012-11-01)

Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan
by: Jung-An Lin, et al.
Published: (2014-10-01)

Lymph node enlargement during combination therapy for chronic hepatitis C with pegylated interferon alpha and ribavirin: harmless reaction or harmful disease?
by: M Wilhelmi, et al.
Published: (2006-01-01)

Dynamics of hepatitis C virus infection
by: Stefan Zeuzem, M.D., et al.
Published: (2002-04-01)

Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study
Published: (2012-01-01)

Importance of adherence for efficacy of hepatitis C combined therapy
by: Nožić Darko, et al.
Published: (2013-01-01)

Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
by: Mario Espinosa, et al.
Published: (2015-05-01)

Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil
by: Francisco Kennedy Scofoni Faleiros de Azevedo, et al.
Published: (2012-03-01)

Treatment of hepatitis C in liver transplant recipients in the Moscow Center for Liver Transplantation within 10 years
by: M. Sh. Khubutia, et al.
Published: (2016-01-01)

Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferon-alpha and ribavirin: A prospective study
by: Ružić Maja, et al.
Published: (2017-01-01)

Chronic hepatitis C treatment in näive patients
by: Jorge Daruich
Published: (2010-01-01)

The interleukin 28B gene polymorphism, rs8099917, in patients with chronic hepatitis C and response to the treatment with pegylated interferon and ribavirin
by: Hamid Kalantari, et al.
Published: (2019-01-01)

Toll-like receptors 7 and 8 mRNA in monocytes of Egyptian children with chronic hepatitis C infection genotype 4 as predictor to “response” interferon and ribavirin treatment
by: Mohammed A. Khedr, et al.
Published: (2016-03-01)

The expirience of IDEAL
by: E. Z. Burnevich
Published: (2014-09-01)

Porphyria cutanea tarda in an HCV-positive liver transplant patient: a case report
by: Adriano M. Pellicelli, M.D., et al.
Published: (2012-11-01)

Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment
by: Yaakov Maor, et al.
Published: (2014-11-01)

İnterferon ve ribavirin tedavisiyle gelişen plevral efüzyon
by: Aziz Öğütlü, et al.
Published: (2015-09-01)

Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
by: Tseng CW, et al.
Published: (2016-03-01)

Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
by: Sundaram V, et al.
Published: (2016-06-01)

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
by: Nishikawa Hiroki, et al.
Published: (2012-03-01)

Efficacy of combined antiviral therapy with pegylated interferon α-2a and ribavirin for chronic hepatitis C infection in intravenous drug users
by: Ružić Maja, et al.
Published: (2010-01-01)

Predictors of treatment response in patients with hepatitis C 1b genotype
by: Brjalin Vadim, et al.
Published: (2013-12-01)

Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Edmundo P.A. Lopes, et al.

Therapy with interferon-a plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus
by: Lopes Edmundo P.A., et al.
Published: (2003-01-01)